Dow Up0.51% Nasdaq Up0.24%

Cesca Therapeutics Inc. (KOOL)

-NasdaqCM
1.15 Down 0.01(0.86%) Nov 21, 3:59PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Jun 30, 2013Jun 30, 2012
Total Revenue 15,987   17,963   19,023  
Cost of Revenue10,101  11,598  12,690  
Gross Profit 5,886   6,365   6,333  
Operating Expenses
Research Development3,468  2,991  3,729  
Selling General and Administrative11,458  8,600  7,983  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (9,040) (3,065) (5,379)
Income from Continuing Operations
Total Other Income/Expenses Net -  2,161   -  
Earnings Before Interest And Taxes(9,034)(3,086)(4,986)
Interest Expense -   -   -  
Income Before Tax(9,034)(3,086)(4,986)
Income Tax Expense(403) -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(8,631)(3,086)(4,986)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (8,631) (3,086) (4,986)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (8,631) (3,086) (4,986)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.